This topic contains a solution. Click here to go to the answer

Author Question: A client has been diagnosed with cancer. The physician prescribes antineoplastic drug therapy to the ... (Read 117 times)

mwit1967

  • Hero Member
  • *****
  • Posts: 501
A client has been diagnosed with cancer. The physician prescribes antineoplastic drug therapy to the client. Which of the following would the nurse include in the discussion about the prescribed therapy?
 
  A) Leads to complete cure of cancer
  B) Destroys only cancerous cells
  C) Provides complete relief of symptoms of cancer
  D) Delays spread of cancer to other sites

Question 2

A nurse is preparing to administer an antineoplastic drug that is classified as an antimetabolite. Which of the following might the nurse be preparing to give? Select all that apply.
 
  A) Mercaptopurine (Purinethol)
  B) Capecitabine (Xeloda)
  C) Fluorouracil (Adrucil)
  D) Etoposide (Toposar)
  E) Irinotecan (Camptosar)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tennis14576

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

wohoo thank youuu.

Answer to Question 2

Ans: A, B, C
Feedback:
Antimetabolite drugs are substances that incorporate themselves into the cellular components during the S phase of cell division and include mercaptopurine (Purinethol), capecitabine (Xeloda), and fluorouracil (Adrucil). Etoposide and irinotecan are plant alkaloids.





 

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

For a complete list of videos, visit our video library